Treatment of chronic pain requires “multimodal analgesia,” a management plan that often requires pharmacological as well as nondrug therapies, and very importantly large measures of clinician guided patient self-management. Chronic pain
management should rarely, if ever, be opioid mono-therapy. Understanding the clinical role and value of non-opioids, the so called “adjuvant” drugs, improves outcomes and reduces over-reliance on opioids and their demonstrated risks. The conflation of chronic pain management with the prescription of opioids, often at high dose, has for the past 20 years overlooked long-established core tenets of multidisciplinary chronic pain care that is fundamentally about restoring function and enabling behavioral re-training; these are best and more safely accomplished without opioids and other central nervous system depressants. Chronic pain is not a state of opioid deficiency.
You will learn:
- Describe why chronic pain pharmacological treatment should not be opioid mono-therapy.
- Defend the role and value of non-drug options for management of chronic pain.
- Discuss the clinical value and potential side-effects of commonly used “adjuvant” drugs in the management of chronic pain, including anti-inflammatories, antidepressants, and anticonvulsants.
- Understand why, when, and how alternatives to opioids improve outcomes of your pain management plan
David J. Tauben, MD, FACPChief, UW Division of Pain Medicine Clinical Professor
Dr. Tauben, Clinical Professor in Departments of Medicine and Anesthesia & Pain Medicine, board certified in Internal Medicine and Pain Medicine, directs UW Medical Student Pain Education, and is founder of UWTelePain, a video-conference providing education and support to UW Northwest regional primary care providers. A principal investigator for the UW’s NIH Center of Excellence for Pain Education Dr. Tauben studied philosophy at Yale University, medicine at Tufts University, and medical residency at University of Washington.